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Background: Non-randomised studies have suggested that the postoperative complications of (Campos LS,
Limberger LF, Stein AT, Kalil AN) laparoscopic radical hysterectomy are similar to those in abdominal radical
hysterectomy. However, no study evaluating postoperative pain comparing both techniques has been published
thus far. Our objective was to compare pain intensity and other perioperative outcomes between laparoscopic
radical hysterectomy (LRH) and abdominal radical hysterectomy (ARH) in early cervical cancer.
Methods: This single centre, randomised, controlled trial enrolled 30 cervical cancer patients who were clinically
staged IA2 with lymph vascular invasion and IB according to the FIGO (International Federation of Gynaecology and
Obstetrics) classification, and underwent LRH or ARH between late 1999 and early 2004. Postoperative pain, as
measured by a 10-point numerical rate scale, was considered the primary endpoint. Postoperative pain was
assessed every six hours during a patient’s usual postoperative care. Perioperative outcomes were also registered.
Both surgical techniques were executed by the same surgical team. Secondary outcomes included intraoperative
and other postoperative surgicopathological factors and 5-year survival rates.
Results: IA2 patients with lymphatic vascular space invasion and IB cervical cancer patients were randomised to
either the LRH group (16 patients) or the ARH group (14 patients). Four patients (25%) in the LRH group and 5
patients (36%) in the ARH group presented with transoperative or serious postoperative complications. All of the
transoperative complications occurred in the LRH group. The relative risk of presenting with complications was 0.70;
CI 95% (0.23–2.11); P = 0.694. LRH group mean pain score was significantly lower than ARH after 36 h of observation
(P = 0.044; mean difference score: 1.42; 95% CI: 0.04–2.80). The survival results will be published elsewhere.
Conclusions: LRH provided lower pain scores after 36 h of observation in this series. The perioperative and serious
postoperative complications ratios were comparable between the groups.
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Cervical cancer is the second most common cancer
among women worldwide, and 83% of cases occur in de-
veloping countries [1]. In Brazil, the estimated annual in-
cidence is approximately 19 cases per 100,000 women
[2]. Radical hysterectomy with pelvic lymphadenectomy
is a (FIGO) International Federation of Gynaecology and
Obstetrics recommended treatment for early cervical
cancer [3], traditionally performed using the abdominal
approach [4].
The advantages of laparoscopic versus the open ap-
proach for benign gynaecological diseases reported in
the literature include decreased postoperative pain and a
shorter hospital stay [5,6]. Some randomised studies
have reported an increased operative time [6,7].
Previous studies have shown the feasibility and safety
of laparoscopic radical hysterectomy (LRH) [8-10], and
non-randomised controlled studies have suggested that
LRH has an increased operative time [11-13], a shorter
hospital stay [11,12], and fewer postoperative infections
[12] compared with the open approach. A histopatho-
logical comparison of LRH and abdominal radical hys-
terectomy (ARH) suggested that they have the same
radicality [14]. Preliminary data suggested an equivalent
survival rate for the two techniques [13,15].
No randomised trials are available that compare laparo-
scopic radical hysterectomy with abdominal laparoscopic
hysterectomy for treating early cervical cancer. A rando-
mised, prospective international protocol was performed
with 740 patients enrolled to evaluate the feasibility,
complications, quality of life, and survival in early cervical
cancer patients assigned to either abdominal (ARH) or
laparoscopic/robotic radical hysterectomies (LRH). Equi-
valence will be declared if the disease-free survival differ-
ence does not exceed 7% at four years [16].Methods
The detailed eligibility criteria, recruitment details, end-
points, standardisation of surgical procedures, surgical
techniques, sample size calculation and randomisation
methods have been published elsewhere [17]. The sur-
geons that performed the procedures assessed patients
in postoperative care during hospital stay and its compli-
cations; during the follow-up, the same surgeons evalu-
ated and managed the recurrences. The nurses who took
care of the patients and who measured pain as the 5th
vital sign during hospital stay were also not blind.
Parametrial extension, vaginal cuff, and uterosacral liga-
ment sizes were measured by the leading surgeon in the
operative room. Operative time was measured by the
study team surgeons. Other surgicopathological factors
were assessed by the attending pathologist after tissue
processing.Briefly, this is a single centre, randomised, controlled
trial comparing the hysterectomy LRH and ARH proce-
dures. Eligible patients were randomised in either the
LRH or ARH groups. The primary endpoint was postop-
erative pain, as measured by a 10-point numerical rating
scale (NRS) during the postoperative period. Pain was
assessed every 6 h by the nursing staff during a patient’s
usual postoperative care; the nursing staff had been trained
at the beginning of the study. One day pre-surgery, they
were reminded to ask each patient to score her pain level
from 0–10; the nursing staff was unaware of the study ob-
jective. The secondary outcomes were intraoperative and
postoperative complications, histopathological characteris-
tics, overall survival and disease-free survival; these out-
comes were registered prospectively.
Inclusion criteria
The following inclusion criteria were applied: women ≥18
years who sought treatment for histologically confirmed pri-
mary squamous, adenocarcinoma, or adenosquamous cer-
vical cancer that was diagnosed by biopsy or cervical
conization and clinically staged according to the FIGO clas-
sification of IA2 with IB or II A lymph vascular invasion [3].
Exclusion criteria
The following exclusion criteria were applied: patients
with clinically advanced disease (IIB-IV), previous pelvic
or abdominal radiotherapy, pregnancy or clinical diseases
that would preclude one or both surgical approaches (pul-
monary obstructive disease poorly controlled or contra-
indicating prolonged Trendelenburg position, severe hip
disease precluding the use of the dorsolithotomy position;
inadequate bone marrow, renal, or hepatic function); obes-
ity; previous abdominal or pelvic surgery and demographic
factors were not considered exclusion criteria.
Each surgery was performed by the same team. The lead-
ing surgeon (LFC) performed all of the surgeries, and the
other team members were first or second assistants (RK
and LSC). The leading surgeon had performed more than
one hundred abdominal radical hysterectomies before
performing laparoscopic radical hysterectomies. Before the
beginning of the study, a surgeon with expertise in abdom-
inal radical hysterectomies standardised the surgical tech-
nique by evaluating the digital records of the laparoscopic
radical hysterectomies that were performed by the first sur-
geon. To evaluate oncologic adequacy, the leading surgeon
measured the parametrial and vaginal tissue in the opera-
tive room before processing the tissue [18].
Surgical techniques
Laparoscopic radical hysterectomy and laparoscopic pelvic
lymphadenectomy
Both procedures were performed as previously described
[8,9,19]; LRH involves placing a uterine manipulator
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ity was obtained though insertion of Verres needle and
insufflation before placement of a 10-mm trocar. Lap-
aroscopic radical hysterectomy was performed according
to Piver III classification for a radical hysterectomy [20].
The vaginal cuff was sutured laparoscopically. Close-
suction drainage was placed until the daily drainage fell
below 100 mL.
ARH was performed according to the Piver type III
classification for a radical hysterectomy [20]. Access to
the abdominal cavity was obtained through a vertical
midline skin incision.Anaesthesia and postoperative analgesia
The same team of anaesthesiologists performed anaes-
thesia following a defined protocol: midazolam 15 mg
orally one hour before surgery, IV access and standard
monitoring. General anaesthesia was induced with fen-
tanyl 3 μg/kg and propofol 2 mg/kg. Orotracheal intub-
ation was facilitated by atracurium 0.5 mg/kg. After
intubation, the lungs were ventilated with 50% O2, 50%
N2O, and 2% sevoflurane. At the beginning of the
lymphadenectomy, ketoprofen 100 mg and metoclopra-
mide 10 mg were administrated via IV. Before the
extubation, dipyrone 15 mg/kg IV, and morphine 0.05
mg/kg SC were administered. Residual neuromuscular
blockade was antagonised with neostigmine and atropine
when necessary.
Postoperative analgesia: Day 1, diclofenac 75 mg IM
BID, dipyrone (15 mg/kg) IV QID and morphine 0.05
mg/kg mg SC every four hours; Day 2, diclofenac 50 mg
PO tid and morphine 3 mg SC every four hours (onFigure 1 Study flowchart.demand); Day 3, diclofenac 50 mg PO on demand and
morphine 3 mg SC every four hours (on demand).
Adjuvant radiotherapy/chemotherapy
At the discretion of the responsible physician, the histo-
pathological findings were used to determine the need
for adjuvant postoperative treatment.
Postoperative follow-up
All of the patients were evaluated by the study team in the
early postoperative period. The long-term follow-up was a
minimum of five years by the study team or the patients’
assistant physician. Periodically, contact was made with
the assistant physician by the surgeons of the study team
to ascertain the patients’ status. All serious complications
were documented and managed by the study team.
Assessing perioperative complications
All of the transoperative and serious postoperative com-
plications were noted. We analysed the proportion of
patients presenting with perioperative complications in
both groups.
Sample size calculation
The NRS scale was considered the primary postoperative
endpoint. We expected a 55% difference in pain scale in-
tensity between the groups. The sample size was calcu-
lated by Epi Info version 6.04b software in a 1:1 sample,
and we obtained 30 patients.
Randomisation
The patients were randomly assigned to groups using
a random number table of 180 five-digit numbers
Table 3 Surgery-related complications
Complications ARH LRH N*
Cystotomy 0 2 2
Bowel injury 0 2 2
Ureterostenosis 1 0 1
Ureterovaginal fistula 0 1 1
Vesicovaginal fistula 0 2 2
Rectovaginal fistula 0 1 1
DVT**/PE 0 1 1
Intra-abdominal infection 3 1 4
*Some patients presented more than one complication.
**Deep venous thrombosis/Pulmonary embolism.
Table 1 Patient characteristics
Variables1 ARH (14) LRH (16)
Age 39.64 ± 6.23 36.19 ± 9.78
Number of pregnancies 3.5 (3.0–4.0) 2.5 (1.5–3.5)*
Smoking 6 (43%) 5 (31%)
Previous conization 6 (43%) 8 (50%)
Previous abdominal or pelvic surgery 5 (36%) 7 (44%)
1Described as mean ± standard deviation or median (percentile 25–75),
if quantitative. If categorical n (%).
*P <0.05.
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participate in patient selection, surgery or follow-up.
After informed consent signing and prior to surgery, a
random allocation number was determined with a tele-
phone call.Statistical analysis
Continuous variables with normal distribution were
analysed using Student’s t-test for independent samples
and described by means and standard deviation, whereas
those not consistent with normal distribution were
analysed using the Mann-Whitney U test and described
as medians and percentiles. The discrete variables were
compared using Pearson’s χ2 test, and Fisher’s exact test
was used when any cell was <5. The pain scores and in-
tergroups were analysed with an ANOVA for the re-
peated measures, and the Bonferroni correction was
applied as necessary. Statistical significance was set at
P <0.05. The statistical software package SPSS (Statistical
Package for the Social Sciences) version 18.0 was used
for all data analysis.Ethical considerations
The Ethics Committee of Grupo Hospitalar Conceição
approved the study protocol in 1999. This protocol wasTable 2 Surgicopathological factors
Variables ARH (14) LRH (16)
Squamous 12 (86%) 12 (75%)
Adenocarcinoma 2 (14%) 4 (25%)
LVSI1 6 (43%) 4 (25%)
Lymph nodes (number) 19.43 ± 6.35 19.5 ± 8.41
Right parametrial tissue2 4.14 ± 1.56 6.44 ± 2.59*
Left parametrial tissue2 4.01 ± 1.42 6.33 ± 2.2*
Right uterosacral ligament 2.34 ± 0.91 2.78 ± 1.1
Left uterosacral ligament 2.26 ± 0.97 2.67 ± 1.1
Vaginal cuff 2.41 ± 1.18 3.17 ± 1.28
Operative time 240.36 ± 26.85 264.38 ± 49.29
1LVSI: Lymph vascular space invasion; 2Measured in cm.
*P <0.05.registered at ClinicalTrials.gov. Written informed con-
sent was obtained from all patients prior to enrolment.
Results
From 1999 to 2004, 30 patients were included in this
trial and underwent randomisation; 16 were submitted
to LRH and 14 to ARH (Figure 1). No conversion to
laparotomy occurred in the LRH group. Table 1 shows
some patient characteristics; Table 2 shows the surgico-
pathological factors. There was no difference in the
pelvic lymph node count between the LRH and ARH
groups. Parametrial extension was significantly longer
for patients submitted to LRH compared to ARH
(P = 0.07 for the right parametrium and P = 0.002 for the
left parametrium) (Table 2). There was no difference in
operative time between the groups.
Table 3 shows all the transoperative and serious
postoperative complications. Some patients presented
with more than one complication. There were four
transoperative complications, all in the LRH group. Two
patients underwent inadvertent cystotomies during blad-
der dissections; both were recognised intraoperatively
and sutured laparoscopically. One patient presented with
left renal exclusion three months after surgery and
underwent nephrostomy. Ten months after the LRH,
she presented with a vesicovaginal fistula and underwent
a successful surgical correction. Two years after LRH,
the patient underwent a left nephrectomy. The other pa-
tient had an otherwise uncomplicated recovery.
One patient underwent a rectal injury that was sutured
vaginally, and on the 14th postoperative day, she
presented with a ureterovaginal fistula, which was ini-
tially unsuccessfully managed with a JJ catheter. She later
underwent a successful correction of the fistula 30 daysTable 4 Transoperative and postoperative complications
Variables ARH (14) LRH (16)
Complication 5 (36%) 4 (25%)
No complication 8 (65%) 8 (75%)
ARH: Abdominal radical hysterectomy; LRH: Laparoscopic radical hysterectomy.
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jury unrecognised at the time of surgery and required an
additional laparotomy the day after the LRH. An emer-
gency descending colectomy and a colostomy were
performed with washing of the cavity. She developed
sepsis and deep venous thrombosis, and underwent a
vesicovaginal fistula correction during a subsequent hos-
pitalisation. She also presented with a rectovaginal fistula
24 months after LRH. This patient has been disease-free
for 9 years and was fitted with a colostomy pouch. In
the ARH group, one patient developed ureterostenosis
after undergoing pelvic radiation indicated for positive
pelvic lymph nodes; three patients group presented with
abdominal sepsis and had favourable outcomes; and one
was diagnosed with renal exclusion and underwent a
nephrectomy.
Four (25%) patients in the LRH group presented with
transoperative complications, but none of the patients in
the ARH group presented with transoperative complica-
tions (Fisher’s exact test = 0.10). Three patients (19%) in
the LRH group presented with serious postoperative
complications, and five patients (36%) presented with
postoperative complications in the ARH group (Fisher
exact test: 0.417). Table 4 and Additional file 1: Figure
S1 shows the proportion of patients who presented with
transoperative and serious postoperative complications
(analysed together). In total, 36% (five) of the patients in
the ARH group and 25% (four) of the patients in the
LRH group presented with serious complications. The
relative risk of presenting complications was 0.70, 95%Figure 2 Postoperative pain scores 36 hours after surgery.CI (0.23–2.11), P = 0.694. No difference was found in the
proportion of women who presented with transoperative
or serious postoperative complications in this series.
Figure 2 shows postoperative pain curves. LRH group
mean pain score was significantly lower than ARH after
36 h of observation (P = 0.044; mean difference score:
1.42; 95% CI: 0.04–2.80) (Figure 2). In the LRH group, one
patient (6%) requested “on demand” morphine; in the
ARH group, two patients (15%) requested “on demand”
morphine (Fisher exact test 0.586) (See also Additional file
2: Figure S2).
Discussion
Laparoscopic radical hysterectomy had lower pain scores
compared with abdominal radical hysterectomy in this
series. Some studies comparing laparoscopic procedures
in benign gynaecologic diseases with abdominal or vagi-
nal procedures support our findings. A recent study
randomised 41 patients who underwent laparoscopic
hysterectomy (LH) and 41 patients who underwent vagi-
nal hysterectomy (VH) for benign diseases. Postoperative
pain was the primary endpoint and was measured using
a 10-point verbal analogue scale (VAS). The LH group
showed lower VAS pain scores than the VH group at 1,
3, 8, and 24 hours post-surgery [21]. A randomised study
compared 19 patients who underwent laparoscopic myo-
mectomy and 21 patients who underwent abdominal
myomectomy. The pain scores were measured using a
10-point VAS. The laparoscopic myomectomy group
had significantly lower pain scores than the abdominal
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P >0.01) and 72 h (1.1 ± 3.7 P >0.01) post-surgery [7]. A
meta-analysis compared laparoscopy versus laparotomy
in benign ovarian tumours. The odds of being pain free
at 24–48 hours post-surgery were significantly greater
for laparoscopy (110 patients) than laparotomy (108 pa-
tients) at 24–48 hours post-surgery [5]. VAS and NRS
are considered equally accurate in assessing postopera-
tive pain and superior to a four-point verbal categorical
rating scale [22].
The differences in the evaluated pain scores can be
explained as follows. First, laparoscopic surgery uses
electrosurgical devices for dissection and coagulation,
whereas abdominal procedures require clamps, scissors
and tying knots, particularly when used in abdominal
radical hysterectomy. Therefore, ARH like other open
techniques, could cause a wider inflammatory reaction
[23,24]. Second, wider incisions are subjected to more
tension, which can lead to more pain [25]. The use of
morphine “on demand” can alter the results, but we be-
lieve that this use did not interfere with our results, as
there was no significant difference in the morphine re-
quest between the LRH and ARH groups.
To our knowledge, there is no randomised controlled
trial published on laparoscopic radical hysterectomy
versus abdominal radical hysterectomy that must be
performed entirely by laparoscopic approach [26,27]. A
randomized controlled trial comparing laparoscopically
assisted vaginal radical hysterectomy and ARH was pub-
lished, where the inferior part of parametrium and
paracolpium were transected by vaginal approach [28].
This study included patients with tumours <2 cm and
postoperative pain was measured by the amount of anal-
gesic consumption [28]. Postoperative acute pain can be
reliably measured by NRS and VAS, which are considered
correlated [29]. They function best for the patient’s sub-
jective feeling of present pain intensity. They may be used
for worst, least, or average pain over last 24 h, or during
the last week [22]. One of the strengths of the present
study was the fact that assessment of present pain inten-
sity as 5th vital sign was performed every 6 hours.
The current study shows that LRH and ARH do not dif-
fer in terms of postoperative complications. Four patients
presented with transoperative complications, and three of
those presented with postoperative complications that
could be consequences of the first complication presented.
Studies of laparoscopic surgery for benign gynaecologic
conditions show a lower rate of complications than abdom-
inal procedures. A recent meta-analysis comparing abdom-
inal, laparoscopic and vaginal hysterectomy showed that
laparoscopic hysterectomy showed fewer wound or abdom-
inal infections [25]. A comparative retrospective study com-
paring LRH (n = 35) with ARH (n = 54) described 18% vs.
53%, respectively, febrile complication rates (P = 0.001)[12]. A prospective study with retrospective controls com-
pared 50 women submitted to LRH with 48 women sub-
mitted to ARH (controls); a comparative rate of urinary
complications was observed in both groups [30]. Different
surgical skill levels can decrease the performance of a sur-
gical technique [31]. One limitation of our study was the
fact that patient inclusion occurred during the learning
curve of the leading surgeon; performing this trial at the
beginning of the main surgeon’s training period most
likely contributed to the LRH complication rate. A Finnish
cohort of all hysterectomies performed in Finland from
1993 to 2005 reported a progressive decrease in serious
complications for laparoscopic hysterectomies [32].
Oncological safety is always a concern in surgical stud-
ies. We included the parametrial extension measures to
evaluate the surgical radicality, as proposed by Spirtos
[8]. A retrospective comparative study comparing LRH
(n = 34) with ARH (n = 37) found similar parametrial ex-
tensions: 3.8 cm (2.3–6.5) vs. 3.4 (1.7–7.0), P = 0.59; left
parametrium 3.6 cm (2–6) vs. 3.5 (1.5–6.5), P = 0.82
[14]. A comparative retrospective study comparing LRH
(n = 35) with ARH (n = 54) also found no differences in
the parametrial extension [12]. Because we were not
expecting any difference in the parametrial extension,
we did not use any blinding. Longer parametrial exten-
sion measures for LRH could be explained by the magni-
fication of tissue with the laparoscope, allowing a safer
dissection near the bony pelvis.
Conclusions
LRH presented lower pain scores after 36 h of observa-
tion in this series. The complication frequency was
similar. Further studies are required to ascertain a com-
parable long-term survival rate.
Additional files
Additional file 1: Figure S1. Transoperative and Postoperative
complication.
Additional file 2: Figure S2. Distribution of Pain Scores.
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